NCT07082452 2025-07-24SEVENAZAGustave Roussy, Cancer Campus, Grand ParisPhase 3 Not yet recruiting262 enrolled
NCT04578600 2025-04-24CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell LymphomaUniversity of California, DavisPhase 1 Completed8 enrolled
NCT00005639 2019-01-11Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Completed34 enrolled
NCT00413478 2015-06-305-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic LeukemiaM.D. Anderson Cancer CenterPhase 2 Terminated9 enrolled 2 charts